AIM-102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AIM-102, covering 2014-02-14 to 2014-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma [Phase 2]